Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. - Wikidata - awgldk - TriplyDB

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

http://www.wikidata.org/entity/Q34979725

about

Epithelial Sodium Channels in Pulmonary Epithelial Progenitor and Stem Cells Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome Recent advances in understanding and treating ARDS Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic Acute respiratory distress syndrome following cardiovascular surgery: current concepts and novel therapeutic approaches Exosomes and Exosomal miRNA in Respiratory Diseases Genetically modified mesenchymal stromal cells in cancer therapy Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials Influenza lung injury: mechanisms and therapeutic opportunities Adipose-derived mesenchymal stem cells modulate CD14++CD16+ expression on monocytes from sepsis patients in vitro via prostaglandin E2.Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis Are nestin-positive mesenchymal stromal cells a better source of cells for CNS repair?Cellular therapies in trauma and critical care medicine: Looking towards the future In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Therapeutic targeting of acute lung injury and acute respiratory distress syndrome.Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin.Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung Further observations on the behavioral and neural effects of bone marrow stromal cells in rodent pain models.In Vivo Tracking of Systemically Administered Allogeneic Bone Marrow Mesenchymal Stem Cells in Normal Rats through Bioluminescence Imaging.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Dynamic Tracking Human Mesenchymal Stem Cells Tropism following Smoke Inhalation Injury in NOD/SCID Mice.Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice.Trauma and Stem Cells: Biology and Potential Therapeutic Implications.Alveolar Fluid Clearance in Pathologically Relevant Conditions: In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome.Personalized medicine for ARDS: the 2035 research agenda.The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.Current Perspectives in Mesenchymal Stromal Cell Therapies for Airway Tissue Defects.Circulating Progenitor Cells and Childhood Cardiovascular Disease.What's new in cell therapies in ARDS?The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities.Concise Review: The Bystander Effect: Mesenchymal Stem Cell-Mediated Lung Repair.

P2860

Q26738501-F548D0D1-4B4C-41DF-B719-B20BB8BC72A7 Q26740632-C7C31523-DE5B-472B-B1DF-F1E2DD77D742 Q26751256-4BF1D0E6-ABDD-4174-BCB8-FF23334C3C12 Q26770098-0E7E2255-566E-4A91-9A3B-2719C571D672 Q26774850-70E4637A-FE81-4952-B0CE-BEFEDEFB9EC7 Q26795447-D41B712E-1B08-4F1C-B4E7-8E30A95BA026 Q26800196-7D3B6600-200C-4D1D-A869-124FEAC2D5BA Q27693319-5E1DA915-732B-40CB-B281-1A8132799604 Q28066319-BADF9000-C3D0-4866-8523-7EABCE7BCDA6 Q28071840-40BD8F87-4D97-4756-9198-50879C7430CA Q28071916-ED342CF2-4393-4348-9D7C-16C6E87813FD Q28083505-BB0AE70D-5A84-45C0-858A-51AF9A82B235 Q33608585-123C511A-1937-42B8-9C1D-C8F6713DC988 Q33722392-C9BF0C21-A7CE-4FEB-B55B-9B9CB9D4A6D2 Q33722631-40E6D832-959E-4A2A-9407-849787EA9A2E Q33728374-39AE7791-64F8-42AD-9E13-F9C9C50477DF Q33757255-E2759B02-9B61-455D-8236-5A722EF3B7B7 Q33898175-5699F3D7-EFDA-440F-9518-9F45CA3FDF01 Q36067836-55917A1F-B482-4E77-93C3-F048EE98528E Q36253821-56751F48-3A14-43C8-9FB2-70C605B8FC77 Q36500869-2089B1E7-6986-4AFE-96FF-E7A3C244CB45 Q36770476-DCFADCD5-5DCE-4A71-8ABC-C33F19B2258F Q36852274-8790DEA0-68FA-4FBB-8107-8CA4D381536D Q37000249-61789F4F-9E8C-46F9-B5B0-73F4F8475F5B Q37090004-56BB7183-E2A3-4091-ABA2-479F0F218F46 Q37114799-64DAEAE8-ED87-4422-8AC8-55A7FBE6F159 Q37218759-154E49F3-4E60-4846-9C8D-6C573F4D487A Q37276584-0CDFF41E-41B0-4A17-B024-9A7D43E3643B Q37306802-6B3ED7B9-C0D6-49EA-841D-DA2F897AFD0B Q37614303-6C0AB911-0EFB-4B24-9727-FE427C45D982 Q37683107-C165A837-9E8B-4B12-AA7F-665804DEC3A9 Q37729178-044C9BF0-FC72-4944-993A-4CCA6C50D40B Q37740568-4E94344A-C3B7-4602-BBAF-D17DB216E933 Q38381656-1B2B299D-ACDD-4E1C-BFC6-689CE88CE2C1 Q38442767-5E6B39D2-3B72-4D4E-8408-3D78DD0958C5 Q38545834-188E3A30-C629-42B1-9687-5203577F071F Q38629574-DD308B57-BFA7-4E59-9479-414D9BCFA24B Q38655210-5AC34DE1-00FB-4A68-9544-36FB94307783 Q38770657-4211CFBC-49EE-42C3-8EBC-04935F89F799 Q38780160-6043AEF2-D13B-4E2E-8FB5-588D055BEE0A

P2860

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

http://www.wikidata.org/entity/Q34979725

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@ast

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@en

type

label

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@ast

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@en

prefLabel

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@ast

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@en

P1433

Q34979725-1C3B645B-4215-408B-8CC4-F94D99621CD3

P1476

Q34979725-F9C32E9A-FCEA-4A92-9FB8-04F3EFCFC890

P2093

Q34979725-02EC1ACC-B9DF-4AB3-A005-EA0C7ACACC64

Q34979725-4408393E-1CDD-4D38-88CE-AF9AB0949F84

Q34979725-557A25D8-5C1C-4ED9-AD6A-00099E62F1FF

Q34979725-5CF35310-0304-406E-BDB0-44DE8DB4589D

Q34979725-6F24002C-CED1-475E-B02E-18DAFD824CDD

Q34979725-738F95EE-AFBF-4A9E-8B40-35940CFAC05D

Q34979725-7922370B-C6E4-41C3-BF89-02F41155E634

Q34979725-7B4A445C-FBE2-44EB-93F7-265A31430AF3

Q34979725-8AE2CB85-A901-44F6-838D-1F7E7E881DEE

Q34979725-90AD1D7A-E147-47A2-8B01-0DCCE63538B7

P2860

Q34979725-00808BCC-3A3D-4BF1-8643-2C1104897F8B

Q34979725-00B894E2-3B42-4B2A-B7A2-E8EECC8C8D54

Q34979725-05B8D646-858E-4E94-9053-08A76F6DD670

Q34979725-08EAE31F-D476-4767-A12A-2039D1CDBD89

Q34979725-0933B4C5-E133-44AC-8F0E-C217DD9F8B54

Q34979725-0ACE77A3-DEE2-40F1-93DE-7956D1205299

Q34979725-0B50285D-BA33-47B7-B4B0-DB16BE72593A

Q34979725-162E83C5-DAAE-44E2-AA62-52E33B3EE0C3

Q34979725-162F00A5-6799-462F-8A61-CD87344A69CF

Q34979725-225A2CB2-F584-4094-B5D5-F4175839F50A

P304

Q34979725-9F2EACE4-B54D-4F6C-88AD-026078ED1FB7

P31

Q34979725-170B737E-921A-4C79-A6C3-A37510DD7E79

P356

Q34979725-ECF95924-E18E-4C0F-B66E-A5481D689DD2

P433

Q34979725-F9EAC273-2E13-4F79-AB8F-CE97D2AFB13B

P478

Q34979725-46E3F13F-A734-421B-BC41-EA97B21EF5A4

P50

Q34979725-3CBF7ADD-37C9-407B-9B93-57EEB4572B52

Q34979725-F2BA7308-DCE2-4E13-AEAA-9B6AB9865A63

P577

Q34979725-A53408DA-F824-492A-935A-820E5C68A779

P698

Q34979725-640DFBB8-76DC-4C9E-9503-6DD5BE01EDCE

P921

Q34979725-390C99C1-C00F-45D8-9B69-22E548A1CC01

Q34979725-440A7986-ADFA-4DF9-86C8-55B528FC6A9C

P932

Q34979725-18CD983E-9A5F-4E5D-99A1-85CA513CA4FD

P356

S2213-2600(14)70291-7

P1433

The Lancet. Respiratory medicine

P1476

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

@en

P2093

Andrew Leavitt

http://www.w3.org/2001/XMLSchema#string

Angela J Rogers

http://www.w3.org/2001/XMLSchema#string

B Taylor Thompson

http://www.w3.org/2001/XMLSchema#string

David McKenna

http://www.w3.org/2001/XMLSchema#string

Ednan K Bajwa

http://www.w3.org/2001/XMLSchema#string

Hanjing Zhuo

http://www.w3.org/2001/XMLSchema#string

Jae-Woo Lee

http://www.w3.org/2001/XMLSchema#string

Jeanine Wiener-Kronish

http://www.w3.org/2001/XMLSchema#string

Jennifer G Wilson

http://www.w3.org/2001/XMLSchema#string

Joseph Levitt

http://www.w3.org/2001/XMLSchema#string

P2860

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

Serial evaluation of the SOFA score to predict outcome in critically ill patients

Acute respiratory distress syndrome: the Berlin Definition

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.

The effect of prone positioning on mortality in patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials

Neuromuscular blockers in early acute respiratory distress syndrome.

Prone positioning in severe acute respiratory distress syndrome.

An expanded definition of the adult respiratory distress syndrome.

P304

24-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S2213-2600(14)70291-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michael Matthay

P577

2014-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25529339

http://www.w3.org/2001/XMLSchema#string

P921

acute respiratory distress syndrome

phase I clinical trial

P932

4297579

http://www.w3.org/2001/XMLSchema#string